Last reviewed · How we verify
Tribenzor of Daichi Sankyo Inc. USA
Tribenzor of Daichi Sankyo Inc. USA is a Small molecule drug developed by Torrent Pharmaceuticals Limited. It is currently in Phase 1 development.
At a glance
| Generic name | Tribenzor of Daichi Sankyo Inc. USA |
|---|---|
| Sponsor | Torrent Pharmaceuticals Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions (PHASE1)
- Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tribenzor of Daichi Sankyo Inc. USA CI brief — competitive landscape report
- Tribenzor of Daichi Sankyo Inc. USA updates RSS · CI watch RSS
- Torrent Pharmaceuticals Limited portfolio CI
Frequently asked questions about Tribenzor of Daichi Sankyo Inc. USA
What is Tribenzor of Daichi Sankyo Inc. USA?
Tribenzor of Daichi Sankyo Inc. USA is a Small molecule drug developed by Torrent Pharmaceuticals Limited.
Who makes Tribenzor of Daichi Sankyo Inc. USA?
Tribenzor of Daichi Sankyo Inc. USA is developed by Torrent Pharmaceuticals Limited (see full Torrent Pharmaceuticals Limited pipeline at /company/torrent-pharmaceuticals-limited).
What development phase is Tribenzor of Daichi Sankyo Inc. USA in?
Tribenzor of Daichi Sankyo Inc. USA is in Phase 1.